(Q33731533)

29 July 2017

title

A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity (English)

1 reference

29 July 2017

2

Ellen S Vitetta

1 reference

29 July 2017

1

Joan E Smallshaw

1 reference

29 July 2017

language of work or name

English

0 references

publication date

12 January 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

28

1 reference

29 July 2017

issue

12

1 reference

29 July 2017

page(s)

2428-2435

1 reference

Development of stable influenza vaccine powder formulations: challenges and possibilities

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Ricin poisoning: a comprehensive review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Ricin: mechanism of toxicity, clinical manifestations, and vaccine development. A review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Potency of clinical group B streptococcal conjugate vaccines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Stability of yellow fever vaccine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Respiration and lung function in the mouse, Mus musculus (with a note on mass exponents and respiratory variables).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

The use of anti-ricin antibodies to protect mice intoxicated with ricin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

A novel recombinant vaccine which protects mice against ricin intoxication.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Safety and immunogenicity of lyophilized, live attenuated hepatitis A vaccine in non-human primate model

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2839540

Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody

30 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

Point mutations in the hydrophobic C-terminal region of ricin A chain indicate that Pro250 plays a key role in membrane translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

A single affinity column step method for the purification of ricin toxin from castor beans (Ricinus communis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

Characterization of the freeze sensitivity of a hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.081

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20074685

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.12.081

1 reference

29 July 2017

1 reference

29 July 2017

1 reference